Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study.

Sehoon ParkChung Hee BaekHeounjeong GoYoung Hoon KimSang-Il MinJongwon HaYong Chul KimJung Pyo LeeYon Su KimKyung Chul MoonSu-Kil ParkHajeong Lee

Published in: BMC nephrology (2019)

In conclusion, RAASB may be beneficial for graft prognosis in early allograft IgAN patients who require single antihypertensive medication therapy, by means of reducing albuminuria. Further investigation of treatment strategy in allograft IgAN is warranted.

Keyphrases

kidney transplantation
angiotensin ii
angiotensin converting enzyme
blood pressure
healthcare
emergency department
combination therapy
mesenchymal stem cells
replacement therapy
smoking cessation